The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia
Open accessAbstract
The metabolism of low density lipoprotein (LDL, beta lipoprotein) was studied in 10 normal individuals and 10 patients with familial type II hyperlipoproteinemia using purified radioiodinated LDL. Over 97% of the label was bound to the protein moiety of LDL and therefore the turnover data reflect the fate and distribution of LDL-apoprotein. Comparison of the metabolic behavior of biologically screened and unscreened labeled LDL preparations in dogs as well as the analysis of the urinary excretion of radioiodide derived from labeled LDL degradation in humans indicated that no significant denaturation resulted from the isolation, purification, and labeling techniques. The plasma concentration of LDL-cholesterol in normals was 105+/-21 mg/100 ml (mean +/-1 SD) in contrast to 254+/-47 mg/100 mg in patients with type II hyperlipoproteinemia; these values corresponded to LDL-apoprotein concentrations of 63+/-13 mg/100 ml and 153+/-30 mg/100 ml, respectively. Despite these differences in concentration, the synthetic rate of LDL-apoprotein in both groups was not significantly different (14.43+/-1.75 mg/kg per day in normals vs. 15.01+/-1.71 mg/kg per day in type II) nor was there any difference in the fraction of the total exchangeable LDL which was in the intravascular space (68.4+/-4.3% vs. 73.3+/-5.2%). However, the fractional catabolic rate of LDL in normal individuals differed significantly from that of patients with type II hyperlipoproteinemia (0.462+/-0.077/day in normals vs. 0.237+/-0.044/day in type II) and correspondingly the biological half-life of LDL was significantly prolonged (3.08+/-0.35 days normals vs. 4.68+/-0.44 days in type II). These data indicate that the pathologic elevation of plasma LDL concentration in the individuals with type II hyperlipoproteinemia studied here is due to a decreased fractional rate of LDL degradation rather than to an abnormality of LDL synthesis. This defect of catabolism may be the primary defect in type II hyperlipoproteinemia or, alternatively, may be secondary to an underlying abnormality in lipid metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Phosphorus Assay in Column Chromatography
Bartlett, G. R. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70226-3 · Cited by 12,801
Efficient Trace-labelling of Proteins with Iodine
McFARLANE, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,543
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,910
Self-citationThe Theory of Tracer Experiments with 131I-Labelled Plasma Proteins
Matthews, C. M. E. (1957) · Physics in Medicine & Biology · doi:10.1088/0031-9155/2/1/305 · Cited by 829
Waldmann, T. A., & Strober, W. (2015) · Chemical Immunology and Allergy · doi:10.1159/000385919 · Cited by 723
Self-citationThe Metabolic Basis of Inherited Disease
Gutman, A. B. (1972) · Hospital Practice · doi:10.1080/21548331.1972.11706203 · Cited by 573
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701122760206 · Cited by 499
Self-citationSharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer.
Lees, R. S., & Ft, H. (1963) · PubMed · Cited by 482
Hirayama, C. (1968) · SEIBUTSU BUTSURI KAGAKU · doi:10.2198/sbk.13.201 · Cited by 347
Cited by
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Regulation of Plasma Cholesterol by Lipoprotein Receptors
Brown, M. S., Kovanen, P. T., & Goldstein, J. L. (1981) · Science · doi:10.1126/science.6261329 · Cited by 702
Mechanisms of disease: genetic causes of familial hypercholesterolemia
Soutar, A. K., & Naoumova, R. P. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0836 · Cited by 608
NARC-1/PCSK9 and Its Natural Mutants
Benjannet, S., Rhainds, D., Essalmani, R., Mayne, J., Wickham, L., Jin, W., Asselin, M.-C., Hamelin, J., Varret, M., Allard, D., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409699200 · Cited by 587
Bilheimer, D. W., Grundy, S. M., Brown, M. S., & Goldstein, J. L. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.13.4124 · Cited by 557
Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome
Rabbani, N., & Thornalley, P. J. (2012) · Amino Acids · doi:10.1007/s00726-010-0783-0 · Cited by 430
High Density Lipoprotein Metabolism in Man
Blum, C. B., Levy, R. I., Eisenberg, S., Hall, M., Goebel, R. H., & Berman, M. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108833 · Cited by 405
Self-citationPLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIA
Thompson, G. R., Lowenthal, R., & Myant, N. B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92193-5 · Cited by 390
Lipoprotein apoprotein metabolism.
Schaefer, E. J., Eisenberg, S., & Levy, R. I. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41267-2 · Cited by 385
Self-citationShepherd, J., Packard, C. J., Grundy, S. M., Yeshurun, D., Gotto, A. M., & Taunton, O. D. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39842-4 · Cited by 357
Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism
Shepherd, J., Packard, C. J., Bicker, S., Lawrie, T. D. V., & Morgan, H. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005293022202 · Cited by 357
Apolipoprotein B: Structural and Metabolic Heterogeneity
Kane, J. P. (1983) · Annual Review of Physiology · doi:10.1146/annurev.ph.45.030183.003225 · Cited by 349
Goldstein, J. L., & Brown, M. S. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.10.2804 · Cited by 338
Atherosclerosis: The low-density lipoprotein receptor hypothesis
Goldstein, J. L., & Brown, M. S. (1977) · Metabolism · doi:10.1016/0026-0495(77)90119-6 · Cited by 336
Sigurdsson, G., Nicoll, A., & Lewis, B. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108229 · Cited by 308
Kissebah, A. H., Alfarsi, S., & Adams, P. W. (1981) · Metabolism · doi:10.1016/0026-0495(81)90064-0 · Cited by 295
Abnormalities of Lipoprotein Metabolism in Patients with the Nephrotic Syndrome
Joven, J., Villabona, C., Vilella, E., Masana, L., Albertí, R., & Vallés, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008303230905 · Cited by 292
Osborne, J. C., & Brewer, H. B. (1977) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60220-x · Cited by 285
Turnover of Lipoprotein (a) in Man
Krempler, F., Kostner, G. M., Bolzano, K., & Sandhofer, F. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109813 · Cited by 278
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
CHAIT, A., ALBERS, J. J., & BRUNZELL, J. D. (1980) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1980.tb00004.x · Cited by 277
Thompson, G. R., Soutar, A. K., Spengel, F. A., Jadhav, A., Gavigan, S. J., & Myant, N. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2591 · Cited by 274
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Behbodikhah, J., Ahmed, S., Elyasi, A., Kasselman, L. J., De Leon, J., Glass, A. D., & Reiss, A. B. (2021) · Metabolites · doi:10.3390/metabo11100690 · Cited by 270
Importance of growth hormone for the induction of hepatic low density lipoprotein receptors.
Rudling, M., Norstedt, G., Olivecrona, H., Reihnér, E., Gustafsson, J. A., & Angelin, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6983 · Cited by 269
Cianflone, K., Yasruel, Z., Rodriguez, M., Vas, D., & Sniderman, A. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42269-2 · Cited by 269
Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.
SNIDERMAN, A. D., WOLFSON, C., TENG, B., FRANKLIN, F. A., BACHORIK, P. S., & KWITEROVICH, P. O. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-6-833 · Cited by 266
Denke, M. A., Fox, M. M., & Schulte, M. C. (1993) · The Journal of Nutrition · doi:10.1093/jn/123.6.1047 · Cited by 264
Brown, M. S., & Goldstein, J. L. (1974) · Science · doi:10.1126/science.185.4145.61 · Cited by 260
Teng, B., Sniderman, A. D., Soutar, A. K., & Thompson, G. R. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112360 · Cited by 256
EISENBERG, S., & LEVY, R. I. (1975) · Advances in Lipid Research · doi:10.1016/b978-0-12-024913-8.50008-4 · Cited by 255
Self-citationInhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans.
Illingworth, D. R., Harris, W. S., & Connor, W. E. (1984) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.4.3.270 · Cited by 254
Chait, A., Bierman, E. L., & Albers, J. J. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109587 · Cited by 254
Shaikh, M., Wootton, R., Nordestgaard, B. G., Baskerville, P., Lumley, J. S., La Ville, A. E., Quiney, J., & Lewis, B. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.569 · Cited by 206
Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.
Krempler, F., Kostner, G. M., Roscher, A., Haslauer, F., Bolzano, K., & Sandhofer, F. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110896 · Cited by 157
Thornalley, P. J., & Rabbani, N. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.03.025 · Cited by 133
Rudling, M. J., Reihnér, E., Einarsson, K., Ewerth, S., & Angelin, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3469 · Cited by 112
(1990) · PubMed · Cited by 88
Metabolism of apolipoprotein C–I in normolipoproteinemic human subjects
MALMENDIER, C., LONTIE, J., GRUTMAN, G., & DELCROIX, C. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90063-8 · Cited by 27
Metadata
- Authors
- Langer, T., Strober, W., & Levy, R. I.
- Venue
- Journal of Clinical Investigation
- Published
- 1972-06-01
- Volume
- 51
- Issue
- 6
- Pages
- 1528-1536
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2002700276
- Cited by
- 629
- References
- 24
- FWCI
- 49.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.